Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hirschowitz

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
The American Journal of Psychiatry|May 1, 1997
SPECT studies of D2 occupancy in low-dose haloperidol treatmentJ Hirschowitz, R Hitzemann, S Vallabhajosula
Journal of Psychiatric Research|January 1, 1984
Membrane abnormalities in the psychoses and affective disordersR Hitzemann, J Hirschowitz, D Garver
Annals of Internal Medicine|August 1, 1979
Danazol and thyroid functionJ Wortsman, J Hirschowitz, N Soler
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1997
Effect of haloperidol dose on iodine-123-IBZM brain SPECT imaging in schizophrenic patientsS Vallabhajosula, J Hirschowitz, J Machac
British Medical Journal|May 6, 1978
Side effects of cyproheptadineJ Wortsman, N G Soler, J Hirschowitz
The Hillside Journal of Clinical Psychiatry|January 1, 1986
Possible efficacy of alprazolam in restless leg syndromeM B Scharf, L Brown, J Hirschowitz
The American Journal of Psychiatry|January 1, 1989
Clonazepam treatment of five lithium-refractory patients with bipolar disorderT A Aronson, S Shukla, J Hirschowitz
Archives of General Psychiatry|May 1, 1984
Lithium ratio in vitro. Diagnosis and lithium carbonate response in psychotic patientsD L Garver, R Hitzemann, J Hirschowitz
Annals of Internal Medicine|June 1, 1979
Cyproheptadine in the management of the galactorrhea-amenorrhea syndromeJ Wortsman, N G Soler, J Hirschowitz
The American Journal of Psychiatry|May 1, 1982
Growth hormone levels and lithium ratios as predictors of success of lithium therapy in schizophreniaJ Hirschowitz, F P Zemlan, D L Garver
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
The American Journal of Psychiatry|May 1, 1997
SPECT studies of D2 occupancy in low-dose haloperidol treatmentJ Hirschowitz, R Hitzemann, S Vallabhajosula
Journal of Psychiatric Research|January 1, 1984
Membrane abnormalities in the psychoses and affective disordersR Hitzemann, J Hirschowitz, D Garver
Annals of Internal Medicine|August 1, 1979
Danazol and thyroid functionJ Wortsman, J Hirschowitz, N Soler
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1997
Effect of haloperidol dose on iodine-123-IBZM brain SPECT imaging in schizophrenic patientsS Vallabhajosula, J Hirschowitz, J Machac
British Medical Journal|May 6, 1978
Side effects of cyproheptadineJ Wortsman, N G Soler, J Hirschowitz
The Hillside Journal of Clinical Psychiatry|January 1, 1986
Possible efficacy of alprazolam in restless leg syndromeM B Scharf, L Brown, J Hirschowitz
The American Journal of Psychiatry|January 1, 1989
Clonazepam treatment of five lithium-refractory patients with bipolar disorderT A Aronson, S Shukla, J Hirschowitz
Archives of General Psychiatry|May 1, 1984
Lithium ratio in vitro. Diagnosis and lithium carbonate response in psychotic patientsD L Garver, R Hitzemann, J Hirschowitz
Annals of Internal Medicine|June 1, 1979
Cyproheptadine in the management of the galactorrhea-amenorrhea syndromeJ Wortsman, N G Soler, J Hirschowitz
The American Journal of Psychiatry|May 1, 1982
Growth hormone levels and lithium ratios as predictors of success of lithium therapy in schizophreniaJ Hirschowitz, F P Zemlan, D L Garver
Pageof 6